Human TNF-alpha Protein, His Tag, active trimer (MALS verified)
分子別名(Synonym)
DIF, TNF-alpha, TNFA, TNFSF2, cachexin, cachectin, TNFα
表達區(qū)間及表達系統(tǒng)(Source)
Human TNF-alpha Protein, His Tag (TNA-H5228) is expressed from human 293 cells (HEK293). It contains AA Val 77 - Leu 233 (Accession # NP_000585.2).
Predicted N-terminus: Val 77
蛋白結(jié)構(gòu)(Molecular Characterization)

This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 18.3 kDa. The protein migrates as 17-19 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.
內(nèi)毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method / rFC method.
純度(Purity)
>95% as determined by SDS-PAGE.
>95% as determined by SEC-MALS.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.


背景介紹
腫瘤壞死因子α(TNFα)是一種主要由單核細胞和巨噬細胞產(chǎn)生的細胞因子,存在于組織中的滑膜細胞和巨噬細胞內(nèi)。其核心功能是調(diào)節(jié)免疫細胞活性:既能誘導(dǎo)細胞凋亡和炎癥反應(yīng),亦可抑制腫瘤發(fā)生與病毒復(fù)制。TNFα分泌失調(diào)與多種人類疾病相關(guān),包括重度抑郁癥、阿爾茨海默病及惡性腫瘤。
該因子的重組形式作為免疫刺激劑應(yīng)用于臨床,國際非專利藥品名(INN)為他索納明(tasonermin)。在惡性腫瘤病理狀態(tài)下,TNFα可發(fā)生異位分泌,其引發(fā)繼發(fā)性高鈣血癥的作用機制及關(guān)聯(lián)癌癥類型與甲狀旁腺素高度相似。
關(guān)鍵字: TNF-alpha;TNF-alpha蛋白;TNF-alpha重組蛋白;ACRO;百普賽斯;
百普賽斯集團ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國、美國、瑞士等12個城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長期、穩(wěn)定的合作伙伴關(guān)系。集團旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。